3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
2
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Cyclophosphamide
21
fludarabine
17
Specimen Handling
13
Magnetic Resonance Spectroscopy
10
pembrolizumab
9
Nivolumab
9
Radiotherapy
7
Cisplatin
7
fludarabine phosphate
5
Injections
5
tislelizumab
4
daratumumab
4
Rituximab
4
Paclitaxel
4
Ipilimumab
4
Interleukin-2
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Fluorouracil
4
Drug Therapy
4
Doxorubicin
4
Dexamethasone
4
Carboplatin
4
Biopsy
4
venetoclax
3
toripalimab
3
X-Rays
3
Radiosurgery
3
Platinum
3
Oxaliplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Receptors, Interleukin-8B
×
Clear all
NCT06946680
2026-05-22
Peds IMPACT
University of Florida
Phase 1
Not yet recruiting
24 enrolled
NCT07569263
2026-05-06
IMPACT MET
University of Florida
Phase 1
Not yet recruiting
12 enrolled